SHENOUDA MAGED purchased 1466.6% of their position (32.67K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $125.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/31/2024ACC: 0001213900-24-008559
+32.67K
Net shares
Net buyer
$125.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
32.67K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10.80K
Price / share
$3.65
Trade value
$39.45K
% of position
484.7%
1/29/2024
2.23K→13.03K
Common Stock
Direct
Shares
+15K
Price / share
$3.89
Trade value
$58.32K
% of position
115.1%
1/30/2024
13.03K→28.03K
Common Stock
Direct
Shares
+6.88K
Price / share
$4.06
Trade value
$27.94K
% of position
24.5%
1/31/2024
28.03K→34.90K
Total
Net shares
+32.67K
Net value
$125.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2024 | P · Purchase | +10.80K | $3.65 | $39.45K | 484.7% | 2.23K | 13.03K |
| Common Stock Direct | 1/30/2024 | P · Purchase | +15K | $3.89 | $58.32K | 115.1% | 13.03K | 28.03K |
| Common Stock Direct | 1/31/2024 | P · Purchase | +6.88K | $4.06 | $27.94K | 24.5% | 28.03K | 34.90K |
| Total | +32.67K | $125.72K | ||||||
Derivative Transactions0
No derivative transactions reported